Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 280 No 7499 p508
26 April 2008

This article
Reprint   Photocopy

PDF 70K, Acrobat Reader

Letters

• White Paper
• Patient records
• Electronic prescribing
• Pharmacy contract
• Community pharmacy
• Medicines use reviews
• Minor ailment scheme
• Medication errors
• English Pharmacy Board
• Council election
• Education
• Public relations
• New professional body
• The Society (2)
• Euthanasia (2)


Letters to the Editor

Euthanasia

Terminally ill must have right to choose (Professor A. R. Michell)

We need spiritual debate and leadership (Mr A. J. T. Low)

Terminally ill must have right to choose

From Professor A. R. Michell, MRCVS

The case argued in my Broad spectrum article (PJ, 8 March 2008, p272) is not based on a single emotive experience, as one correspondent seems to suggest (PJ, 12 April 2008, p438); I have written about these issues in the national press, and spoken about them at meetings and on television, long before that.

It is based on a lifetime of experience in the only profession — veterinary medicine — which, in the UK, has experience of having assisted closure as an option for the relief of irreversible suffering.

My experience of nursing a dying human patient reinforced, all too vividly, the fact that pain and suffering can reach beyond the power of even the finest palliative care. The question then is, if patients have made it clear, while still thinking coherently, that in such circumstances they would prefer the battle to end, why this most important of choices should be denied to them. To continue to deny it, in a country with a secular majority, and a majority in favour of such a change, is a cruel offence against human rights.

The two bastions of resistance, the higher value on human life and the danger of mistaken choice, are both addressed in my article. How can a higher value on human life lead to human patients being treated in a way that would be unethical, even illegal, if inflicted on animals?

And, if the risk of regretted outcomes were a justification for withholding choice, would we forbid riding, rugby, skateboarding or military service? As for undermining confidence in doctors, it is the patient’s choice, not theirs.

The essence of freedom is choice, the price of choice is the risk of error and, if we believe in patient choice, few choices, if any, are more important than those concerning the manner of our dying. These issues will increasingly confront pharmacists as the NHS, rightly, tries to facilitate the wish of the majority of the terminally ill, to be at home rather than in a clinical environment.

We all need to recognise that what seems right for us may seem wrong for others and should not be forced upon them as an outdated relic of a religion they may not share.

Bob Michell
Nether Worton, Oxfordshire
Lay member of the Royal Pharmaceutical Society’s Council


We need spiritual debate and leadership

From Mr A. J. T. Low, MRPharmS

I read Bob Michell’s heartfelt Broad spectrum article (PJ, 8 March 2008, p272) on “assisted closure” in terminal illness and greatly admire him for addressing this issue.

It is good to see health professionals debating the circumstances of dying. It cannot just be brushed under the carpet as we hope for the best. As a society we have become alienated and distanced from the details and processes of dying.

In pharmacy we are not usually involved directly in the care of the dying, in that our role is usually confined to supplying medicines, such as palliative analgesics for a patient who may be dying at home. So, perhaps, we tend to forget the enormous emotional content of these situations.

Professor Michell makes the point that there are arguments both for and against euthanasia and that arguments like the possibility of a miraculous recovery (on the “contra” side) are “wheeled onto the barbican” to defend the established position set against assisted dying. These are much more abstract considerations than we usually face in community pharmacy certainly, and it is good to see that those with the beliefs and ability can debate these complex moral issues in an open manner in the right forums.

Ultimately, Professor Michell addressed advanced and complicated questions, and we need spiritual guidance from the right quarters to guide us forward. These are not light issues and we would not want to be without some sort of spiritual debate and leadership.

Andrew Low
Harrow, Middlesex

Send your letter to The Editor

Previous Topic (The Society)

Back to Top


©The Pharmaceutical Journal